Virpax Pharmaceuticals (VRPX) Stock Chart & Stock Price History → The only accurate crypto trading system I know … (From Weiss Ratings) (Ad) Free VRPX Stock Alerts $3.09 -0.07 (-2.22%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Virpax Pharmaceuticals Stock Price Performance5 Day Performance-11.91%1 Month Performance-21.09%3 Month Performance+4.71%6 Month Performance-57.03%Year-To-Date Performance-0.66%1 Year Performance-56.44% Receive VRPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsThe only accurate crypto trading system I know …Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.Here's what our expert says you should buy before April 14. VRPX Stock Chart for Thursday, April, 25, 2024 VRPX Chart by TradingView Virpax Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$3.32$3.16-4.82%$3.30$3.0011,455 shs$3.70 million04/22/2024$3.68$3.32-9.79%$3.65$3.2316,065 shs$3.89 million04/19/2024$3.91$3.61-7.67%$3.95$3.615,952 shs$4.22 million04/18/2024$3.47$3.91+12.68%$3.91$3.3120,060 shs$4.58 million04/17/2024$3.47$3.47$3.47$3.301,922 shs$4.06 million04/16/2024$3.53$3.47-1.71%$3.47$3.282,753 shs$4.06 million Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$3.55$3.53-0.55%$3.53$3.301,498 shs$4.13 million04/12/2024$3.61$3.55-1.66%$3.55$3.259,177 shs$4.15 million04/11/2024$3.66$3.61-1.37%$3.62$3.611,020 shs$4.22 million04/10/2024$3.51$3.66+4.27%$3.70$3.511,983 shs$4.28 million04/09/2024$3.72$3.51-5.65%$3.65$3.347,381 shs$4.11 million04/08/2024$3.89$3.72-4.37%$4.05$3.4526,846 shs$4.36 million04/05/2024$4.09$3.89-4.89%$3.96$3.6116,955 shs$4.55 million04/04/2024$4.16$4.09-1.68%$4.17$3.991,554 shs$4.79 million04/03/2024$4.17$4.16-0.24%$4.24$4.073,428 shs$4.87 million04/02/2024$4.21$4.17-0.95%$4.24$4.007,667 shs$4.88 million04/01/2024$4.26$4.21-1.20%$4.27$3.979,687 shs$4.93 million03/29/2024$4.14$4.26+2.93%$4.26$3.7215,504 shs$4.99 million03/28/2024$3.77$4.14+9.81%$4.26$3.7215,504 shs$4.85 million03/27/2024$3.88$3.77-2.84%$3.97$3.487,669 shs$4.41 million03/26/2024$3.74$3.88+3.74%$3.90$3.6914,431 shs$4.54 million03/25/2024$4.03$3.74-7.20%$3.99$3.705,409 shs$4.38 million03/22/2024$4.14$4.03-2.66%$4.30$3.7124,347 shs$4.72 million03/21/2024$4.39$4.14-5.69%$4.69$4.0027,130 shs$4.84 million03/20/2024$4.18$4.39+5.02%$4.82$4.0981,090 shs$5.14 million03/19/2024$3.73$4.18+12.06%$4.30$3.4972,624 shs$4.89 million03/18/2024$4.17$3.73-10.53%$3.96$3.534,278 shs$4.37 million03/15/2024$3.87$4.17+7.75%$4.20$3.4015,644 shs$4.88 million03/14/2024$3.50$3.87+10.57%$3.89$3.3447,197 shs$4.53 million03/13/2024$4.02$3.50-12.94%$3.94$3.4820,807 shs$4.10 million03/12/2024$4.95$4.02-18.79%$4.86$3.78100,795 shs$4.70 million03/11/2024$4.53$4.95+9.27%$5.48$4.52539,398 shs$5.79 million03/08/2024$4.23$4.53+7.09%$4.78$4.3031,192 shs$5.30 million03/07/2024$3.98$4.23+6.28%$4.52$4.0013,756 shs$4.95 million03/06/2024$4.25$3.98-6.35%$4.46$3.8536,612 shs$4.66 million03/05/2024$3.66$4.25+16.12%$4.34$3.7123,702 shs$4.97 million03/04/2024$3.51$3.66+4.27%$3.79$3.5210,027 shs$4.29 million03/01/2024$3.05$3.50+14.68%$3.71$2.6439,582 shs$40.99 million02/29/2024$3.10$3.05-1.58%$3.15$3.055,226 shs$3.58 million02/28/2024$2.90$3.10+6.82%$3.22$2.8010,825 shs$3.63 millionThe "Smart Money" Is Ready for May 1st Are You? (Ad)Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why…02/27/2024$3.40$2.90-14.62%$3.12$2.8914,605 shs$3.40 million02/26/2024$3.38$3.40+0.59%$3.49$3.358,678 shs$3.98 million02/23/2024$3.15$3.30+4.77%$3.38$3.163,349 shs$3.86 million02/22/2024$3.00$3.15+4.83%$3.16$2.8011,857 shs$3.68 million02/21/2024$2.70$3.00+11.11%$3.30$2.7024,156 shs$3.51 million02/20/2024$3.31$2.70-18.43%$3.50$2.7013,449 shs$3.16 million02/19/2024$3.31$3.31$3.62$3.108,570 shs$3.88 million02/16/2024$3.68$3.31-9.96%$3.62$3.108,573 shs$3.88 million02/15/2024$3.86$3.68-4.77%$3.88$3.505,536 shs$4.31 million02/14/2024$3.69$3.86+4.49%$3.86$3.515,308 shs$4.52 million02/13/2024$3.59$3.69+2.81%$3.80$3.604,678 shs$4.33 million02/12/2024$3.70$3.59-2.89%$3.80$3.493,459 shs$4.21 million02/09/2024$3.75$3.70-1.23%$3.99$3.506,909 shs$4.33 million02/08/2024$3.84$3.75-2.32%$3.99$3.364,134 shs$4.39 million02/07/2024$4.14$3.84-7.46%$4.17$3.5047,070 shs$4.49 million02/06/2024$3.78$4.14+9.63%$4.18$3.8014,916 shs$4.85 million02/05/2024$3.39$3.78+11.60%$4.00$3.2028,421 shs$4.43 million02/02/2024$3.49$3.39-2.81%$3.70$3.203,877 shs$3.97 million02/01/2024$3.29$3.49+5.93%$4.00$3.1614,796 shs$4.08 million01/31/2024$3.25$3.29+1.20%$3.30$3.103,594 shs$3.85 million01/30/2024$3.18$3.25+2.30%$3.30$3.101,026 shs$3.81 million01/29/2024$3.10$3.18+2.48%$3.27$3.101,607 shs$3.72 million01/26/2024$3.11$3.11$3.30$3.102,346 shs$3.64 million01/25/2024$3.04$3.11+2.40%$3.27$3.022,095 shs$3.64 million01/24/2024$3.07$3.04-1.07%$3.30$3.013,229 shs$3.56 million01/23/2024$3.07$3.07+0.13%$3.28$3.07977 shs$3.60 million Related Companies: MBIO Stock Price Chart EVOK Stock Price Chart GOVX Stock Price Chart PHAS Stock Price Chart REVB Stock Price Chart HILS Stock Price Chart ENSC Stock Price Chart PHIO Stock Price Chart SNGX Stock Price Chart BCEL Stock Price Chart Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRPX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.